Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 218

1.

Challenges in the design of a T cell vaccine in the context of HIV-1 diversity.

Tongo M, Burgers WA.

Viruses. 2014 Oct 23;6(10):3968-90. doi: 10.3390/v6103968.

PMID:
25341662
[PubMed - in process]
Free PMC Article
2.

Novel vaccine vectors for HIV-1.

Barouch DH, Picker LJ.

Nat Rev Microbiol. 2014 Nov;12(11):765-71. doi: 10.1038/nrmicro3360. Epub 2014 Oct 8.

PMID:
25296195
[PubMed - in process]
Free PMC Article
3.

An assessment of fishing communities around Lake Victoria, Uganda, as potential populations for future HIV vaccine efficacy studies: an observational cohort study.

Kiwanuka N, Mpendo J, Nalutaaya A, Wambuzi M, Nanvubya A, Kitandwe PK, Muyanja E, Ssempiira J, Balyegisawa A, Ssetaala A; UVRI-IAVI Research Team.

BMC Public Health. 2014 Sep 22;14:986. doi: 10.1186/1471-2458-14-986.

PMID:
25242015
[PubMed - in process]
Free PMC Article
4.

The influence of delivery vectors on HIV vaccine efficacy.

Ondondo BO.

Front Microbiol. 2014 Aug 22;5:439. doi: 10.3389/fmicb.2014.00439. eCollection 2014. Review.

PMID:
25202303
[PubMed]
Free PMC Article
5.

Designing peptide-based HIV vaccine for Chinese.

Shu J, Fan X, Ping J, Jin X, Hao P.

Biomed Res Int. 2014;2014:272950. doi: 10.1155/2014/272950. Epub 2014 Jul 6.

PMID:
25136573
[PubMed - in process]
Free PMC Article
6.

Differential glycosylation of envelope gp120 is associated with differential recognition of HIV-1 by virus-specific antibodies and cell infection.

Raska M, Czernekova L, Moldoveanu Z, Zachova K, Elliott MC, Novak Z, Hall S, Hoelscher M, Maboko L, Brown R, Smith PD, Mestecky J, Novak J.

AIDS Res Ther. 2014 Aug 1;11:23. doi: 10.1186/1742-6405-11-23. eCollection 2014.

PMID:
25120578
[PubMed]
Free PMC Article
7.

Microdevices for examining immunological responses of single cells to HIV.

Choi J, Jeong Y, Han HS, Lee KH.

Biosci Rep. 2014 Aug 18;34(4). pii: e00134. doi: 10.1042/BSR20140097.

PMID:
25028990
[PubMed - in process]
Free PMC Article
8.

Advancing Toward HIV-1 Vaccine Efficacy through the Intersections of Immune Correlates.

Tomaras GD, Haynes BF.

Vaccines (Basel). 2014 Mar;2(1):15-35.

PMID:
24932411
[PubMed]
Free PMC Article
9.

Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.

Chanzu N, Ondondo B.

Front Immunol. 2014 May 8;5:202. doi: 10.3389/fimmu.2014.00202. eCollection 2014. Review.

PMID:
24847327
[PubMed]
Free PMC Article
10.

Analysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial.

Gartland AJ, Li S, McNevin J, Tomaras GD, Gottardo R, Janes H, Fong Y, Morris D, Geraghty DE, Kijak GH, Edlefsen PT, Frahm N, Larsen BB, Tovanabutra S, Sanders-Buell E, deCamp AC, Magaret CA, Ahmed H, Goodridge JP, Chen L, Konopa P, Nariya S, Stoddard JN, Wong K, Zhao H, Deng W, Maust BS, Bose M, Howell S, Bates A, Lazzaro M, O'Sullivan A, Lei E, Bradfield A, Ibitamuno G, Assawadarachai V, O'Connell RJ, deSouza MS, Nitayaphan S, Rerks-Ngarm S, Robb ML, Sidney J, Sette A, Zolla-Pazner S, Montefiori D, McElrath MJ, Mullins JI, Kim JH, Gilbert PB, Hertz T.

J Virol. 2014 Aug;88(15):8242-55. doi: 10.1128/JVI.01164-14. Epub 2014 May 14.

PMID:
24829343
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Vaccines for the 21st century.

Delany I, Rappuoli R, De Gregorio E.

EMBO Mol Med. 2014 May 6;6(6):708-20. doi: 10.1002/emmm.201403876.

PMID:
24803000
[PubMed - in process]
Free PMC Article
12.

Novel HIV vaccine strategies: overview and perspective.

Cohen YZ, Dolin R.

Ther Adv Vaccines. 2013 Sep;1(3):99-112. doi: 10.1177/2051013613494535.

PMID:
24757518
[PubMed]
Free PMC Article
13.

Preventive and therapeutic applications of neutralizing antibodies to Human Immunodeficiency Virus Type 1 (HIV-1).

Ringe R, Bhattacharya J.

Ther Adv Vaccines. 2013 Jul;1(2):67-80. doi: 10.1177/2051013613494534.

PMID:
24757516
[PubMed]
Free PMC Article
14.

Impact of mutations in highly conserved amino acids of the HIV-1 Gag-p24 and Env-gp120 proteins on viral replication in different genetic backgrounds.

Liu Y, Rao U, McClure J, Konopa P, Manocheewa S, Kim M, Chen L, Troyer RM, Tebit DM, Holte S, Arts EJ, Mullins JI.

PLoS One. 2014 Apr 8;9(4):e94240. doi: 10.1371/journal.pone.0094240. eCollection 2014.

PMID:
24713822
[PubMed - in process]
Free PMC Article
15.

Modulation of HIV-1 immunity by adjuvants.

Moody MA.

Curr Opin HIV AIDS. 2014 May;9(3):242-9. doi: 10.1097/COH.0000000000000052.

PMID:
24670321
[PubMed - in process]
Free PMC Article
16.

Statistical approaches to analyzing HIV-1 neutralizing antibody assay data.

Yu X, Gilbert PB, Hioe CE, Zolla-Pazner S, Self SG.

Stat Biopharm Res. 2012 Jan 1;4(1):1-13.

PMID:
24660049
[PubMed]
Free PMC Article
17.

Predicting HIV-1 broadly neutralizing antibody epitope networks using neutralization titers and a novel computational method.

Evans MC, Phung P, Paquet AC, Parikh A, Petropoulos CJ, Wrin T, Haddad M.

BMC Bioinformatics. 2014 Mar 19;15:77. doi: 10.1186/1471-2105-15-77.

PMID:
24646213
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Nonhuman primate models for HIV/AIDS vaccine development.

Sui Y, Gordon S, Franchini G, Berzofsky JA.

Curr Protoc Immunol. 2013 Oct 1;102:Unit 12.14.. doi: 10.1002/0471142735.im1214s102. Review.

PMID:
24510515
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Who will Benefit from a Wide-Scale Introduction of Vaginal Microbicides in Developing Countries?

Dimitrov DT, Masse B, Boily MC.

Stat Commun Infect Dis. 2010 Jan;2(1):1012.

PMID:
24490001
[PubMed]
Free PMC Article
20.

Designing vaccines for the twenty-first century society.

Finco O, Rappuoli R.

Front Immunol. 2014 Jan 23;5:12. doi: 10.3389/fimmu.2014.00012. eCollection 2014. Review.

PMID:
24478777
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk